Literature DB >> 22157586

Essential hypertension: perspectives and future directions.

Songcang Chen.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22157586      PMCID： PMC4152852          DOI： 10.1097/HJH.0b013e32834ee23c

Source DB:  PubMed          Journal:  J Hypertens        ISSN： 0263-6352            Impact factor:   4.844


× No keyword cloud information.
  39 in total

1.  Individual QTLs controlling quantitative variation in blood pressure inherited in a Mendelian mode.

Authors:  C Duong; S Charron; Y Deng; C Xiao; A Ménard; J Roy; A Y Deng
Journal:  Heredity (Edinb)       Date:  2006-11-22       Impact factor: 3.821

2.  Unraveling hypertension: epigenomics comes of age.

Authors:  Myriam Fornage
Journal:  Pharmacogenomics       Date:  2007-02       Impact factor: 2.533

3.  Association of WNK1 gene polymorphisms and haplotypes with ambulatory blood pressure in the general population.

Authors:  Martin D Tobin; Stuart M Raleigh; Stephen Newhouse; Peter Braund; Clare Bodycote; Jenny Ogleby; Deborah Cross; Jay Gracey; Saija Hayes; Terry Smith; Cathy Ridge; Mark Caulfield; Nuala A Sheehan; Patricia B Munroe; Paul R Burton; Nilesh J Samani
Journal:  Circulation       Date:  2005-11-21       Impact factor: 29.690

4.  1,25 dihydroxyvitamin d amplifies type a natriuretic peptide receptor expression and activity in target cells.

Authors:  Songcang Chen; Xi-Ping Ni; Michael H Humphreys; David G Gardner
Journal:  J Am Soc Nephrol       Date:  2004-12-08       Impact factor: 10.121

5.  Novel genes as primary triggers for polygenic hypertension.

Authors:  Cristina Chauvet; Annie Ménard; Chunjie Xiao; Benjamin Aguila; Marilyne Blain; Julie Roy; Alan Y Deng
Journal:  J Hypertens       Date:  2012-01       Impact factor: 4.844

6.  Catecholamine release-inhibitory peptide catestatin (chromogranin A(352-372)): naturally occurring amino acid variant Gly364Ser causes profound changes in human autonomic activity and alters risk for hypertension.

Authors:  Fangwen Rao; Gen Wen; Jiaur R Gayen; Madhusudan Das; Sucheta M Vaingankar; Brinda K Rana; Manjula Mahata; Brian P Kennedy; Rany M Salem; Mats Stridsberg; Kenneth Abel; Douglas W Smith; Eleazar Eskin; Nicholas J Schork; Bruce A Hamilton; Michael G Ziegler; Sushil K Mahata; Daniel T O'Connor
Journal:  Circulation       Date:  2007-04-16       Impact factor: 29.690

7.  Molecular basis of human salt sensitivity: the role of the 11beta-hydroxysteroid dehydrogenase type 2.

Authors:  E Lovati; P Ferrari; B Dick; K Jostarndt; B M Frey; F J Frey; U Schorr; A M Sharma
Journal:  J Clin Endocrinol Metab       Date:  1999-10       Impact factor: 5.958

8.  Epigenetic regulation of 11 beta-hydroxysteroid dehydrogenase type 2 expression.

Authors:  Rasoul Alikhani-Koopaei; Fatemeh Fouladkou; Felix J Frey; Brigitte M Frey
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

9.  1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system.

Authors:  Yan Chun Li; Juan Kong; Minjie Wei; Zhou-Feng Chen; Shu Q Liu; Li-Ping Cao
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

10.  Vitamin D activates type A natriuretic peptide receptor gene transcription in inner medullary collecting duct cells.

Authors:  S Chen; K Olsen; C Grigsby; D G Gardner
Journal:  Kidney Int       Date:  2007-04-18       Impact factor: 10.612
View more
  6 in total

Review 1.  Dysregulation of T cell subsets in the pathogenesis of hypertension.

Authors:  Songcang Chen; Devendra K Agrawal
Journal:  Curr Hypertens Rep       Date:  2015-02       Impact factor: 5.369

Review 2.  Vitamin D deficiency and essential hypertension.

Authors:  Songcang Chen; Yingxian Sun; Devendra K Agrawal
Journal:  J Am Soc Hypertens       Date:  2015-08-21

3.  Downregulation of the β1 adrenergic receptor in the myocardium results in insensitivity to metoprolol and reduces blood pressure in spontaneously hypertensive rats.

Authors:  Yun Huang; Xiao-Li Liu; Jia Wen; Li-Hua Huang; Yao Lu; Ru-Jia Miao; Xing Liu; Ying Li; Xiao-Wei Xing; Hong Yuan
Journal:  Mol Med Rep       Date:  2016-12-14       Impact factor: 2.952

Review 4.  Is Vitamin D Supplementation an Effective Treatment for Hypertension?

Authors:  Songcang Chen; Gio Gemelga; Yerem Yeghiazarians
Journal:  Curr Hypertens Rep       Date:  2022-06-23       Impact factor: 4.592

5.  Low serum 25-hydroxyvitamin D levels may increase the detrimental effect of VDR variants on the risk of essential hypertension.

Authors:  Fang Shen; Changman Guo; Yan Wang; Fei Yu; Dongdong Zhang; Xue Liu; Yue Ba; Chongjian Wang; Wenjie Li; Xing Li
Journal:  Eur J Clin Nutr       Date:  2019-12-11       Impact factor: 4.016

6.  Network Pharmacology Prediction and Pharmacological Verification Mechanism of Yeju Jiangya Decoction on Hypertension.

Authors:  Ting Wang; Mao He; Yuzhong Du; Suhong Chen; Guiyuan Lv
Journal:  Evid Based Complement Alternat Med       Date:  2021-05-10       Impact factor: 2.629
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.